Tonix Pharmaceuticals TNX-102 SL Pharmacokinetic Properties 2024

Loading viewer...

conference

Format: PDF conference

Tonix Pharmaceuticals presents pharmacokinetic data on TNX-102 SL, a novel sublingual formulation of cyclobenzaprine hydrochloride, at the 2024 Pharmaceutics and Novel Drug Delivery Systems Conference. The oral presentation by Bruce Daugherty, PhD, details the formulation development and bioavailability characteristics of this investigational drug candidate.

Browse all conferences →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Tonix Pharmaceuticals Holding Corp.

View all →

Tonix Pharmaceuticals BIO 2024 Corporate Presentation

conference

23 Pages

Tonix Pharmaceuticals Corporate Presentation February 2017

investor_presentation

Similar conferences from other companies

Browse all →

Range Resources Corporation 2016 EnerCom Oil & Gas Conference

conference

23 Pages

Range Resources Corporation

GAN Limited 2021 Vision Day B. Riley Conference

conference